Zurich Cantonal Bank
CGON icon

Zurich Cantonal Bank’s CG Oncology CGON Stock Holding History

Zurich Cantonal Bank’s Portfolio CGON Stock Details CGON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.66M Buy
23,354
+11,745
+101% +$768K ﹤0.01% 1243
2026
Q1 		$786K Buy
11,609
+2,610
+29% +$148K ﹤0.01% 1571
2025
Q4 		$374K Sell
8,999
-7,357
-45% -$304K ﹤0.01% 1937
2025
Q3 		$659K Buy
16,356
+2,900
+22% +$84.3K ﹤0.01% 1569
2025
Q2 		$350K Hold
13,456
– – ﹤0.01% 1872
2025
Q1 		$330K Buy
13,456
+7,600
+130% +$214K ﹤0.01% 1845
2024
Q4 		$168K Sell
5,856
-543
-8% -$18.6K ﹤0.01% 2229
2024
Q3 		$241K Buy
+6,399
New +$224K ﹤0.01% 2008

Other funds holding CGON

RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Zurich Cantonal Bank's CGON Position: Q2 2026 in Review

Zurich Cantonal Bank increased its CG Oncology (CGON) stake by 101% in Q2 2026, buying an estimated $768K and bringing the position to 23,354 shares worth $1.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1243.

Zurich Cantonal Bank first reported a position in CGON in Q3 2024 and has held it in 8 quarters since. 227 funds tracked by Wall St. Rank hold CGON as of Q2 2026.

  • Zurich Cantonal Bank held 23,354 shares of CG Oncology worth $1.66M as of Q2 2026.
  • Zurich Cantonal Bank bought 11,745 CG Oncology shares in Q2 2026, an estimated $768K.
  • CG Oncology made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1243 holding.
  • Zurich Cantonal Bank first reported a position in CG Oncology in Q3 2024 and has held it in 8 quarters since.
  • 227 funds tracked by Wall St. Rank held CG Oncology as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.